Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The FAT atypical cadherin 1 (FAT1) gene is derived from Caenorhabditis elegans C. elegans. The translation product is ω-3 polyunsaturated fatty acid dehydrogenase. The function of this enzyme is to carry out the dehydrogenation reaction with 18-20 carbon ω-6 PUFAs as a substrate to generate corresponding ω-3 PUFAs, which balances ω-in the body. The ratio of 6/ω-3 PUFAs plays an important role in the prevention and treatment of cardiovascular, cerebrovascular, tumor, schizophrenia and other diseases.
Figure 1. FAT1 is an actionable driver-oncogene in OSCC (oral squamous cell carcinoma). (Hsu, T., et al. 2019)
A large number of studies have shown that ω-3 PUFAs in the diet are used as precursors of signal molecules during tumorigenesis, participate in the process of cell signal transduction, inhibit tumor formation at different stages, and promote tumor cell apoptosis. At present, there is a preliminary understanding of the anti-tumor effect of fat-1, but its anti-tumor mechanism is not very clear. Many mechanisms are involved in this anti-cancer effect, including inhibition of tumor cell migration, inhibition of tumor cell growth, and promotion of cell apoptosis.
The study found that compared with the control group, the fat-1 gene transgenic mice had a lower chance of developing colon cancer from colitis. Studies have confirmed that the mechanism of fat-1 transgenic mice against colon cancer caused by colitis is that ω-3 PUFAs work by inhibiting Cox-2 expression and promoting the production of PGE3 and cytokines. In addition, ω-3 PUFAs can also inhibit the formation of uterine cancer, liver tumor, and melanoma, and induce tumor cell apoptosis.
Cardiovascular and cerebrovascular diseases have become the number one killer threatening human health. A large number of studies have confirmed that ω-3 PUFAs not only help prevent the occurrence of cardiovascular diseases, but also have a therapeutic effect on certain cardiovascular diseases. The fat-1 gene-transformed food can increase the content of ω-3 PUFAs in the body, which is of great significance for the prevention and treatment of cardiovascular and cerebrovascular diseases. The researchers constructed fat-1 adenovirus vector Ad. GFP-fat-1 and Ad. GFP blank vector as a reference to transfect mouse cardiomyocytes. Enzyme-linked immunoassay was used to detect the content of PGE2, the main product of ω-6 PUFAs, which was significantly lower than that of the control group.
The study found that providing ω-3 PUFAs to cardiomyocytes can resist arrhythmia. The researchers put mouse cardiomyocytes transfected with fat-1 gene and non-transgene into a high calcium (7.5mM) environment. The control group had arrhythmia. The fat-1 gene-transformed mouse cardiomyocytes maintained normal beating, indicating that the fat-1 gene was successfully integrated into the mouse cardiomyocytes, and its expression helped the cardiomyocytes to resist arrhythmia. Researchers suggest that ordinary people should consume 500mg of omega-3 PUFAs per day, while heart disease patients should consume 800-1000mg per day.
Researchers add omega-3 PUFAs to the diet to optimize bone formation. Using the fat -1 mouse model to synthesize ω-3 PUFAs, it was found that when the ratio of ω-6/ω-3 PUFAs decreased, the bone mineral density (BMD) increased and the maximum load of the vertebrae was compared with that of wild Type increased. This will make the spine stronger. Studies have found that the endogenous synthesis of omega-3 PUFAs in fat-1 mice can prevent osteoporosis caused by ovariectomy. In addition, ω-3 PUFAs also play an important role in alleviating asthma attacks. The endogenous production of ω-3 PUFAs in the lungs of fat-1 mice increased, and by inducing the reduction of airway inflammation, the white blood cells accumulated in the bronchoalveolar and lung soft tissue cells decreased, thereby alleviating the onset of asthma. In addition, the reduction of the ratio of ω-6/ω-3 PUFAs can improve the animal's tolerance to glucose.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.